Professional Documents
Culture Documents
Oral Biopsy Flow Chart
Oral Biopsy Flow Chart
No Dysplasia/ Dysplasia/
Benign1 Malignant1
High Lvl Suspicion3
- Erythroplakia/SCC1 Low Lvl Suspicion3:
2-3 wk. Patient Consent - Positive Velscope results
Follow-up Refer to Oral Surgeon - Pros/Cons - High risk location
or Cancer Clinic3 - Benefit/Risk - Active bleeding w/out
Or: - May req. physical documentation hemostasis
- Avoid triggering vocabulary
Not healed: Lesion Healed
Attempt Therapeutic Dx
- Document progression/
regression (if any) - Remove possible irritants
- Provide tools/topicals PRN
2-3 wk.
- 3-6 mo. Follow up Follow-up
Refer to Oral Surgeon
or Cancer Clinic
- Reinforce OSE
- Continue to
STOP Patient refusal2: STOP Or:
Or: document PRN
- Explain the importance of biopsy and/or following up
- Can’t rule out cancer as a possibility without confirming Not healed: Lesion Healed
- Document progression/
via biopsy regression (if any)
2nd - Offer alternate biopsy/treatment options where applicable
- Documentation of refusal (refusal form)
Biopsy
- Remember: pt has 100% right to refuse treatment/biopsy2 - 3-6 mo. Follow up
or opt to discontinue treatment at any time. - Reinforce OSE
- Continue to
document PRN
3
Biopsy Flow Chart
DHYG 280 Dental Diseases 1
Assign #1 - Lesion Flow Chart Rubric (15%)
REFERENCES:
1. Williams M, Poh CF, Hovan AJ, Ng S, Rosin MP [Internet]. Evaluation of a Suspicious Oral Mucosal Lesion. April 2008;[Cited 2024 Feb 2];
74(3). Available from: https://www.cda-adc.ca/jcda/vol-74/issue-3/275.pdf
2. BCCOHP: Informed Refusal to Consent [Internet]. Interpretation Guidelines: Informed Refusal to Consent. September 2013; [Cited 2024 Feb 2]
Available from: https://oralhealthbc.ca/wp-content/uploads/2022/08/02.02.025-IG-Informed-Refusal-to-Consent.pdf
3. BCCOHP: Guideline for Early Detection of Oral Cancer [Internet]. Guideline for the Early Detection of Oral Cancer in British Columbia. March
2008; [Cited 2024 Feb 2] Available from: https://oralhealthbc.ca/wp-content/uploads/2022/08/03.02.007-Oral-Cancer-Screening.pdf